Mathias Schmidt

Mathias Schmidt

Company: JCR USA

Job title: President & Chief Executive Officer


Virtual Talk: Using Transferrin-Receptor Mediated Transcytosis as Mechanism for the First Approved Biotherapeutic Designed to Cross the Blood Brain Barrier 8:45 am

• Capturing the key translational aspects moving into human trials • Defining moments on the path to approval • Applicability of the technology across modalities and indicationsRead more

day: Day One

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.